Document is current
Any future updates will be listed below
-
Authors
Zuccaro, Michael V.
Young, Randee E.
Hu, Jiangyuan
Lanzano, Patricia
Semenova, Ekaterina
Lin, Xiaoqi https://orcid.org/0009-0009-3678-1674
Skowronski, Alicja
Shen, Yufeng https://orcid.org/0000-0002-1299-5979
Kim, Tae Hyun
Miller, Danny E. https://orcid.org/0000-0001-6096-8601
Germain, Noelle
Sarmiere, Patrick
LeDuc, Charles A. https://orcid.org/0000-0002-2073-5050
Chung, Wendy K. https://orcid.org/0000-0003-3438-5685
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 4 December 2025
First Online: 9 January 2026
Competing interests
: Wendy K. Chung has received research funding from Ovid Therapeutics. Noelle Germaine, Tae Hyun, and Patrick Sarmiere are former employees and consultants of Ovid Therapeutics. Danny E. Miller is on scientific advisory boards at Oxford Nanopore Technologies (ONT) and Basis Genetics, is engaged in a research agreement with ONT, has received research and travel support from ONT, and holds stock options in MyOme and Basis Genetics. The remaining authors declare no competing interests.
